1.

Siqueira RC, NP Vitral, Campos WR, Oréfice F, de Moraes Figueiredo

LT. Manifestasi mata pada demam Dengue. Inflamasi Immunol Ocul . 2004 12
Desember (4): 323-7. [Medline] .
2. Gregory CJ, Santiago LM, Argüello DF, Hunsperger E, Tomashek
KM. Gambaran klinis dan laboratorium yang membedakan demam berdarah dari
penyakit demam lain di daerah endemik - Puerto Rico, 2007-2008. Am J Trop
Med Hyg . 2010 Mei. 82 (5): 922-9. [Medline]. [Teks Lengkap] .
3. Eisen L, Moore CG. Aedes (Stegomyia) aegypti di benua Amerika Serikat: vektor
pada batas sejuk rentang geografisnya. J Med Entomol . 2013 Mei 50 (3): 467-
78. [Medline] .
4. Waduge R, Malavige GN, Pradeepan M, Wijeyaratne CN, Fernando S,
Seneviratne SL. Infeksi Dengue selama kehamilan: serangkaian kasus dari Sri
Lanka dan ulasan literatur. J Clin Virol . 2006 37 September (1): 27-
33. [Medline] .
5. Ismail NA, Kampan N, Mahdy ZA, Jamil MA, Razi ZR. Demam berdarah saat
hamil. Asia Tenggara J Trop Med Kesehatan Masyarakat . 2006 Jul 37 (4): 681-
3. [Medline] .
6. Thomas EA, John M, Kanish B. Manifestasi mukokutan demam berdarah. India
D Dermatol . 2010. 55 (1): 79-85. [Medline] . [Teks Lengkap] .
7. Huang HW, Tseng HC, Lee CH, Chuang HY, Lin SH. Signifikansi klinis ruam kulit
pada demam berdarah: Fokus pada ketidaknyamanan, komplikasi, dan hasil
penyakit. Asian Pac J Trop Med . 2016 9 Jul (7): 713-8. [Medline] . [Teks
Lengkap] .
8. Radakovic-Fijan S, Graninger W, Müller C, Hönigsmann H, Tanew A. Demam
berdarah dengue dalam panduan perjalanan di Inggris. J Am Acad
Dermatol . 2002 Maret 46 (3): 430-3. [Medline] .
9. Liu Y, Liu J, Cheng G. Vaksin dan strategi imunisasi untuk pencegahan demam
berdarah. Emerg Microbies Menginfeksi . 2016 20 Juli. 5 (7):
e77. [Medline] . [Teks Lengkap] .
10. Severson DW, Knudson DL, Soares MB, Loftus BJ. Genomik Aedes
aegypti. Serangga Biochem Mol Biol . 2004 Jul 34 (7): 715-21. [Medline] .
11. Sim S, Hibberd ML. Pendekatan genom untuk memahami demam berdarah:
wawasan dari virus, vektor, dan inang. Genom Biol . 2016 Mar 2.
17:38. [Medline] . [Teks Lengkap] .
12. Vaksin Edelman R. Dengue mendekati garis finish. Clin Infect Dis . 2007 Jul 15.
45 Suppl 1: S56-60. [Medline] .
13. Blaney JE Jr, Durbin AP, Murphy BR, Whitehead SS. Pengembangan vaksin
virus dengue hidup yang dilemahkan menggunakan genetika terbalik. Viral
Immunol . Musim Semi 2006 19 (1): 10-32. [Medline] .
1. World Health Organization. Dengue and severe dengue fact sheet. WHO.
Available at http://www.who.int/mediacentre/factsheets/fs117/en/. April 2017;
Accessed: September 28, 2017.
2. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The
global distribution and burden of dengue. Nature. 2013 Apr 25. 496 (7446):504-
7. [Medline].
3. Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, et al.
Refining the global spatial limits of dengue virus transmission by evidence-based
consensus. PLoS Negl Trop Dis. 2012. 6 (8):e1760. [Medline].
4. Wilson ME, Chen LH. Dengue: update on epidemiology. Curr Infect Dis Rep.
2015 Jan. 17 (1):457. [Medline].
5. Ten threats to global health in 2019. World Health Organization. Available
at https://www.who.int/emergencies/ten-threats-to-global-health-in-2019. 2019;
Accessed: Feb 2, 2019.
6. Kyle JL, Harris E. Global spread and persistence of dengue. Annu Rev Microbiol.
2008. 62:71-92. [Medline].
7. Statler J, Mammen M, Lyons A, Sun W. Sonographic findings of healthy
volunteers infected with dengue virus. J Clin Ultrasound. 2008 Sep. 36(7):413-
7. [Medline].
8. Gubler DJ. Cities spawn epidemic dengue viruses. Nat Med. 2004 Feb.
10(2):129-30. [Medline].
9. Wilder-Smith A, Gubler DJ. Geographic expansion of dengue: the impact of
international travel. Med Clin North Am. 2008 Nov. 92(6):1377-90, x. [Medline].
10. Messina JP, Brady OJ, Scott TW, Zou C, Pigott DM, Duda KA, et al. Global
spread of dengue virus types: mapping the 70 year history. Trends Microbiol.
2014 Mar. 22 (3):138-46. [Medline]. [Full Text].
11. Halstead SB. Dengue. Lancet. 2007 Nov 10. 370(9599):1644-52. [Medline].
12. Chowell G, Torre CA, Munayco-Escate C, Suárez-Ognio L, López-Cruz R,
Hyman JM. Spatial and temporal dynamics of dengue fever in Peru: 1994-
2006. Epidemiol Infect. 2008 Dec. 136(12):1667-77. [Medline].
13. Osterwell N. Dengue 'Under-recognized' as Source of Febrile Illness in US.
Medscape Medical News. Jan 23 2014. Available
at http://www.medscape.com/viewarticle/819656. Accessed: January 25, 2014.
14. Sharp TM, Gaul L, Muehlenbachs A, Hunsperger E, Bhatnagar J, Lueptow R, et
al. Fatal hemophagocytic lymphohistiocytosis associated with locally acquired
dengue virus infection - new Mexico and Texas, 2012. MMWR Morb Mortal Wkly
Rep. 2014 Jan 24. 63(3):49-54. [Medline].
15. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F.
Spectrum of disease and relation to place of exposure among ill returned
travelers. N Engl J Med. 2006 Jan 12. 354(2):119-30. [Medline].
16. Liu-Helmersson J, Quam M, Wilder-Smith A, Stenlund H, Ebi K, Massad E, et al.
Climate Change and Aedes Vectors: 21st Century Projections for Dengue
Transmission in Europe. EBioMedicine. 2016 May. 7:267-77. [Medline].
17. CDC. Imported dengue--United States, 1997 and 1998. MMWR Morb Mortal
Wkly Rep. 2000 Mar 31. 49(12):248-53. [Medline]. [Full Text].
18. Engelthaler DM, Fink TM, Levy CE, Leslie MJ. The reemergence of Aedes
aegypti in Arizona. Emerg Infect Dis. 1997 Apr-Jun. 3(2):241-2. [Medline]. [Full
Text].
19. Chye JK, Lim CT, Ng KB, et al. Vertical transmission of dengue. Clin Infect Dis.
1997 Dec. 25(6):1374-7. [Medline].
20. Wagner D, de With K, Huzly D, Hufert F, Weidmann M, Breisinger S, et al.
Nosocomial acquisition of dengue. Emerg Infect Dis. 2004 Oct. 10(10):1872-
3. [Medline].
21. Dejnirattisai W, Duangchinda T, Lin CL, Vasanawathana S, Jones M, Jacobs M,
et al. A complex interplay among virus, dendritic cells, T cells, and cytokines in
dengue virus infections. J Immunol. 2008 Nov 1. 181(9):5865-74. [Medline].
22. Halstead SB, Heinz FX, Barrett AD, Roehrig JT. Dengue virus: molecular basis of
cell entry and pathogenesis, 25-27 June 2003, Vienna, Austria. Vaccine. 2005
Jan 4. 23(7):849-56. [Medline].
23. Limjindaporn T, Wongwiwat W, Noisakran S, Srisawat C, Netsawang J,
Puttikhunt C, et al. Interaction of dengue virus envelope protein with endoplasmic
reticulum-resident chaperones facilitates dengue virus production. Biochem
Biophys Res Commun. 2009 Feb 6. 379(2):196-200. [Medline].
24. Zhang JL, Wang JL, Gao N, Chen ZT, Tian YP, An J. Up-regulated expression of
beta3 integrin induced by dengue virus serotype 2 infection associated with virus
entry into human dermal microvascular endothelial cells. Biochem Biophys Res
Commun. 2007 May 11. 356(3):763-8. [Medline].
25. Rothman AL, Ennis FA. Immunopathogenesis of Dengue hemorrhagic
fever. Virology. 1999 Apr 25. 257(1):1-6. [Medline].
26. Chen LC, Lei HY, Liu CC, Shiesh SC, Chen SH, Liu HS. Correlation of serum
levels of macrophage migration inhibitory factor with disease severity and clinical
outcome in dengue patients. Am J Trop Med Hyg. 2006 Jan. 74(1):142-
7. [Medline].
27. Green S, Rothman A. Immunopathological mechanisms in dengue and dengue
hemorrhagic fever. Curr Opin Infect Dis. 2006 Oct. 19(5):429-36. [Medline].
28. Guzman MG, Alvarez M, Rodriguez-Roche R, Bernardo L, Montes T, Vazquez S.
Neutralizing antibodies after infection with dengue 1 virus. Emerg Infect Dis.
2007 Feb. 13(2):282-6. [Medline].
29. Restrepo BN, Ramirez RE, Arboleda M, Alvarez G, Ospina M, Diaz FJ. Serum
levels of cytokines in two ethnic groups with dengue virus infection. Am J Trop
Med Hyg. 2008 Nov. 79(5):673-7. [Medline].
30. Rothman AL. Dengue: defining protective versus pathologic immunity. J Clin
Invest. 2004 Apr. 113(7):946-51. [Medline].
31. de Macedo FC, Nicol AF, Cooper LD, Yearsley M, Pires AR, Nuovo GJ.
Histologic, viral, and molecular correlates of dengue fever infection of the liver
using highly sensitive immunohistochemistry. Diagn Mol Pathol. 2006 Dec.
15(4):223-8. [Medline].
32. Shah I. Dengue and liver disease. Scand J Infect Dis. 2008. 40(11-12):993-
4. [Medline].
33. Dejnirattisai W, Jumnainsong A, Onsirisakul N, et al. Cross-reacting antibodies
enhance dengue virus infection in humans. Science. 2010 May 7.
328(5979):745-8. [Medline].
34. Schmidt AC. Response to dengue fever--the good, the bad, and the ugly?. N
Engl J Med. 2010 Jul 29. 363(5):484-7. [Medline].
35. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Ennis FA. High levels
of interferon alpha in the sera of children with dengue virus infection. Am J Trop
Med Hyg. 1993 Feb. 48(2):222-9. [Medline].
36. Ojha A, Nandi D, Batra H, Singhal R, Annarapu GK, Bhattacharyya S, et al.
Platelet activation determines the severity of thrombocytopenia in dengue
infection. Sci Rep. 2017 Jan 31. 7:41697. [Medline].
37. Hottz ED, Oliveira MF, Nunes PC, Nogueira RM, Valls-de-Souza R, Da Poian
AT, et al. Dengue induces platelet activation, mitochondrial dysfunction and cell
death through mechanisms that involve DC-SIGN and caspases. J Thromb
Haemost. 2013 May. 11 (5):951-62. [Medline].
38. Wang E, Ni H, Xu R, Barrett AD, Watowich SJ, Gubler DJ. Evolutionary
relationships of endemic/epidemic and sylvatic dengue viruses. J Virol. 2000 Apr.
74(7):3227-34. [Medline].
39. Centers for Disease Control and Prevention Web site. CDC traveler's health
page. Dengue. Available at http://www.cdc.gov/Dengue/travelOutbreaks/.
Accessed: October 20, 2011.
40. Chen WS, Wong CH, Cillekens L. Dengue antibodies in a suburban community
in Malaysia. Med J Malaysia. 2003 Mar. 58(1):142-3. [Medline].
41. Istúriz RE, Gubler DJ, Brea del Castillo J. Dengue and dengue hemorrhagic fever
in Latin America and the Caribbean. Infect Dis Clin North Am. 2000 Mar.
14(1):121-40, ix. [Medline].
42. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Periago MR. The neglected
tropical diseases of Latin America and the Caribbean: a review of disease burden
and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis.
2008 Sep 24. 2(9):e300. [Medline]. [Full Text].
43. Centers for Disease Control and Prevention (CDC). Travel-associated Dengue
surveillance - United States, 2006-2008. MMWR Morb Mortal Wkly Rep. 2010
Jun 18. 59(23):715-9. [Medline]. [Full Text].
44. Centers for Disease Control and Prevention (CDC). Locally acquired Dengue--
Key West, Florida, 2009-2010. MMWR Morb Mortal Wkly Rep. 2010 May 21.
59(19):577-81. [Medline].
45. Rey JR. Dengue in Florida (USA). Insects. 2014 Dec 16. 5 (4):991-
1000. [Medline].
46. Malavige GN, Fernando S, Fernando DJ, Seneviratne SL. Dengue viral
infections. Postgrad Med J. 2004 Oct. 80(948):588-601. [Medline]. [Full Text].
47. Stephenson JR. Understanding dengue pathogenesis: implications for vaccine
design. Bull World Health Organ. 2005 Apr. 83(4):308-14. [Medline]. [Full Text].
48. World Health Organization. Impact of Dengue. Available
at http://www.who.int/csr/disease/dengue/impact/en/index.html. Accessed:
October 14, 2011.
49. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The
global distribution and burden of dengue. Nature. 2013 Apr 25. 496 (7446):504-
7. [Medline].
50. Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, et al.
Refining the global spatial limits of dengue virus transmission by evidence-based
consensus. PLoS Negl Trop Dis. 2012. 6 (8):e1760. [Medline].
51. Lin CC, Huang YH, Shu PY, et al. Characteristic of dengue disease in Taiwan:
2002-2007. Am J Trop Med Hyg. 2010 Apr. 82(4):731-9. [Medline]. [Full Text].
52. Anderson KB, Chunsuttiwat S, Nisalak A, Mammen MP, Libraty DH, Rothman
AL. Burden of symptomatic dengue infection in children at primary school in
Thailand: a prospective study. Lancet. 2007 Apr 28. 369(9571):1452-9. [Medline].
53. Anker M, Arima Y. Male-female differences in the number of reported incident
dengue fever cases in six Asian countries. Western Pac Surveill Response J.
2011 Apr. 2 (2):17-23. [Medline].
54. Lahiri M, Fisher D, Tambyah PA. Dengue mortality: reassessing the risks in
transition countries. Trans R Soc Trop Med Hyg. 2008 Oct. 102(10):1011-
6. [Medline].
55. Beatty ME, Beutels P, Meltzer MI, et al. Health economics of dengue: a
systematic literature review and expert panel's assessment. Am J Trop Med Hyg.
2011 Mar. 84(3):473-88. [Medline]. [Full Text].
56. Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH. Economic
impact of dengue illness in the Americas. Am J Trop Med Hyg. 2011 Feb.
84(2):200-7. [Medline]. [Full Text].
57. Suaya JA, Shepard DS, Siqueira JB, et al. Cost of dengue cases in eight
countries in the Americas and Asia: a prospective study. Am J Trop Med Hyg.
2009 May. 80(5):846-55. [Medline].
58. WHO. Dengue haemorrhagic fever: diagnosis, treatment, prevention and
control. World Health Organization. 1997. Available
at http://www.who.int/topics/dengue/en/.
59. Sanjay S, Wagle AM, Au Eong KG. Dengue optic neuropathy. Ophthalmology.
2009 Jan. 116(1):170; author reply 170. [Medline].
60. Teves Maria A. Wrong treatment most common cause of dengue fatality.
ABS/CBN News. Available at http://www.abs-
cbnnews.com/nation/09/03/09/wrong-treatment-most-common-cause-dengue-
fatality. Accessed: September 3, 2010.
61. Bottieau E, Clerinx J, Van den Enden E, Van Esbroeck M, Colebunders R, Van
Gompel A. Fever after a stay in the tropics: diagnostic predictors of the leading
tropical conditions. Medicine (Baltimore). 2007 Jan. 86(1):18-25. [Medline].
62. Malhotra N, Chanana C, Kumar S. Dengue infection in pregnancy. Int J Gynaecol
Obstet. 2006 Aug. 94(2):131-2. [Medline].
63. Singh N, Sharma KA, Dadhwal V, Mittal S, Selvi AS. A successful management
of dengue fever in pregnancy: report of two cases. Indian J Med Microbiol. 2008
Oct-Dec. 26(4):377-80. [Medline].
64. Warrilow D, Northill JA, Pyke A, Smith GA. Single rapid TaqMan fluorogenic
probe based PCR assay that detects all four dengue serotypes. J Med Virol.
2002 Apr. 66(4):524-8. [Medline].
65. Kong YY, Thay CH, Tin TC, Devi S. Rapid detection, serotyping and quantitation
of dengue viruses by TaqMan real-time one-step RT-PCR. J Virol Methods. 2006
Dec. 138(1-2):123-30. [Medline].
66. Trung DT, Thao le TT, Hien TT, et al. Liver involvement associated with dengue
infection in adults in Vietnam. Am J Trop Med Hyg. 2010 Oct. 83(4):774-
80. [Medline]. [Full Text].
67. Potts JA, Rothman AL. Clinical and laboratory features that distinguish dengue
from other febrile illnesses in endemic populations. Trop Med Int Health. 2008
Nov. 13(11):1328-40. [Medline]. [Full Text].
68. Lima EQ, Nogueira ML. Viral hemorrhagic fever-induced acute kidney
injury. Semin Nephrol. 2008 Jul. 28(4):409-15. [Medline].
69. Lombardi R, Yu L, Younes-Ibrahim M, Schor N, Burdmann EA. Epidemiology of
acute kidney injury in Latin America. Semin Nephrol. 2008 Jul. 28(4):320-
9. [Medline].
70. Chaterji S, Allen JC Jr, Chow A, Leo YS, Ooi EE. Evaluation of the NS1 rapid
test and the WHO dengue classification schemes for use as bedside diagnosis of
acute dengue fever in adults. Am J Trop Med Hyg. 2011 Feb. 84(2):224-
8. [Medline]. [Full Text].
71. Wichmann O, Stark K, Shu PY, Niedrig M, Frank C, Huang JH. Clinical features
and pitfalls in the laboratory diagnosis of dengue in travellers. BMC Infect Dis.
2006. 6:120. [Medline].
72. Domingo C, de Ory F, Sanz JC, Reyes N, Gascón J, Wichmann O, et al.
Molecular and serologic markers of acute dengue infection in naive and
flavivirus-vaccinated travelers. Diagn Microbiol Infect Dis. 2009 Sep. 65(1):42-
8. [Medline].
73. Srikiatkhachorn A, Krautrachue A, Ratanaprakarn W, Wongtapradit L, Nithipanya
N, Kalayanarooj S. Natural history of plasma leakage in dengue hemorrhagic
fever: a serial ultrasonographic study. Pediatr Infect Dis J. 2007 Apr. 26(4):283-
90; discussion 291-2. [Medline].
74. Santhosh VR, Patil PG, Srinath MG, Kumar A, Jain A, Archana M. Sonography in
the diagnosis and assessment of dengue Fever. J Clin Imaging Sci. 2014.
4:14. [Medline]. [Full Text].
75. Srikiatkhachorn A, Gibbons RV, Green S, et al. Dengue hemorrhagic fever: the
sensitivity and specificity of the world health organization definition for
identification of severe cases of dengue in Thailand, 1994-2005. Clin Infect Dis.
2010 Apr 15. 50(8):1135-43. [Medline]. [Full Text].
76. Setiati TE, Mairuhu AT, Koraka P, Supriatna M, Mac Gillavry MR, Brandjes DP,
et al. Dengue disease severity in Indonesian children: an evaluation of the World
Health Organization classification system. BMC Infect Dis. 2007 Mar 26.
7:22. [Medline]. [Full Text].
77. Tassniyom S, Vasanawathana S, Chirawatkul A, Rojanasuphot S. Failure of
high-dose methylprednisolone in established dengue shock syndrome: a
placebo-controlled, double-blind study. Pediatrics. 1993 Jul. 92(1):111-
5. [Medline].
78. WHO. Dengue. Available at http://www.who.int/topics/dengue/en/. Accessed:
October 20, 2011.
79. Wills BA, Nguyen MD, Ha TL, Dong TH, Tran TN, Le TT, et al. Comparison of
three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med.
2005 Sep 1. 353(9):877-89. [Medline].
80. Yadav SP, Sachdeva A, Gupta D, Sharma SD, Kharya G. Control of massive
bleeding in dengue hemorrhagic fever with severe thrombocytopenia by use of
intravenous anti-D globulin. Pediatr Blood Cancer. 2008 Dec. 51(6):812-
3. [Medline].
81. Waduge R, Malavige GN, Pradeepan M, Wijeyaratne CN, Fernando S,
Seneviratne SL. Dengue infections during pregnancy: a case series from Sri
Lanka and review of the literature. J Clin Virol. 2006 Sep. 37(1):27-33. [Medline].
82. Ismail NA, Kampan N, Mahdy ZA, Jamil MA, Razi ZR. Dengue in
pregnancy. Southeast Asian J Trop Med Public Health. 2006 Jul. 37(4):681-
3. [Medline].
83. Billingsley PF, Foy B, Rasgon JL. Mosquitocidal vaccines: a neglected addition to
malaria and dengue control strategies. Trends Parasitol. 2008 Sep. 24(9):396-
400. [Medline].
84. Erlanger TE, Keiser J, Utzinger J. Effect of dengue vector control interventions
on entomological parameters in developing countries: a systematic review and
meta-analysis. Med Vet Entomol. 2008 Sep. 22(3):203-21. [Medline].
85. Kay B, Vu SN. New strategy against Aedes aegypti in Vietnam. Lancet. 2005 Feb
12-18. 365(9459):613-7. [Medline].
86. Hanh TT, Hill PS, Kay BH, Quy TM. Development of a framework for evaluating
the sustainability of community-based dengue control projects. Am J Trop Med
Hyg. 2009 Feb. 80(2):312-8. [Medline].
87. Hoffmann AA, Montgomery BL, Popovici J, Iturbe-Ormaetxe I, Johnson PH,
Muzzi F, et al. Successful establishment of Wolbachia in Aedes populations to
suppress dengue transmission. Nature. 2011 Aug 24. 476 (7361):454-
7. [Medline].
88. Lang J. Recent progress on sanofi pasteur's dengue vaccine candidate. J Clin
Virol. 2009 Oct. 46 Suppl 2:S20-4. [Medline].
89. World Health Organization. Dengue vaccine: WHO position paper – July
2016. Wkly Epidemiol Rec. 2016 Jul 29. 91 (30):349-64. [Medline].
90. Aguiar M, Stollenwerk N, Halstead SB. The risks behind Dengvaxia
recommendation. Lancet Infect Dis. 2016 Aug. 16 (8):882-3. [Medline]. [Full
Text].
91. Dengvaxia. European Medicines Agency. Available
at https://www.ema.europa.eu/en/medicines/human/EPAR/dengvaxia. 2018 Dec
18; Accessed: Feb 15, 2019.
92. Monath TP. Dengue and yellow fever--challenges for the development and use of
vaccines. N Engl J Med. 2007 Nov 29. 357(22):2222-5. [Medline].
93. McArthur JH, Durbin AP, Marron JA, Wanionek KA, Thumar B, Pierro DJ, et al.
Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4
vaccine candidate designed for decreased hepatotoxicity. Am J Trop Med Hyg.
2008 Nov. 79(5):678-84. [Medline]. [Full Text].
94. O'Brien J. 12th Annual Conference on Vaccine Research. Expert Rev Vaccines.
2009 Sep. 8(9):1139-42. [Medline].
95. Edelman R. Dengue vaccines approach the finish line. Clin Infect Dis. 2007 Jul
15. 45 Suppl 1:S56-60. [Medline].
96. Blaney JE Jr, Durbin AP, Murphy BR, Whitehead SS. Development of a live
attenuated dengue virus vaccine using reverse genetics. Viral Immunol. 2006
Spring. 19(1):10-32. [Medline].
97. Questions and Answers on Dengue Vaccines. World Health Organization.
Available
at https://www.who.int/immunization/research/development/dengue_q_and_a/en/
. 2018 April 20; Accessed: February 10, 2019.
98. Larsen CP, Whitehead SS, Durbin AP. Dengue human infection models to
advance dengue vaccine development. Vaccine. 2015 Sep 28. [Medline].
99. Anker M, Arima Y. Male-female differences in the number of reported incident
dengue fever cases in six Asian countries. Western Pac Surveill Response J.
2011 Apr. 2 (2):17-23. [Medline].